ArticleNAM journal2026
Semi-automated, evidence-based workflow for selection of reference chemicals for the validation of NAMs: a case study with the adipogenesis assay.
Article in NAM journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The validation of in vitro New Approach Methodologies (NAMs) requires the use of well-characterized reference chemicals to assess assay performance, reproducibility, and relevance. However, selecting such chemicals is often labor-intensive and lacks standardization. We developed a semi-automated, evidence-based workflow that integrates systematic literature review, AI-assisted data extraction, and quantitative evidence scoring to improve the efficiency and transparency of chemical selection. We conducted a structured EMBASE search, followed by AI-assisted abstract screening and data extraction, in a case study to select reference chemicals for the validation of an in vitro adipogenesis assay. Chemicals were evaluated for in vitro, in vivo, and human evidence of adipogenic or obesogenic effects. From 11,648 screened publications, 236 studies met the inclusion criteria, resulting in the identification of 243 candidate reference chemicals, of which 50 were prioritized based on scoring. The final selection encompassed a set of 22 chemicals with different levels of potency and diverse structures. This workflow illustrates how AI-assisted evidence synthesis can accelerate and standardize the selection of reference chemicals while maintaining expert oversight and ensuring regulatory relevance. It provides a reproducible and adaptable framework for future NAMs validation studies across diverse toxicological endpoints.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.